JP2002520300A5 - - Google Patents

Download PDF

Info

Publication number
JP2002520300A5
JP2002520300A5 JP2000558851A JP2000558851A JP2002520300A5 JP 2002520300 A5 JP2002520300 A5 JP 2002520300A5 JP 2000558851 A JP2000558851 A JP 2000558851A JP 2000558851 A JP2000558851 A JP 2000558851A JP 2002520300 A5 JP2002520300 A5 JP 2002520300A5
Authority
JP
Japan
Prior art keywords
formula
composition
compound
composition according
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000558851A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002520300A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013947 external-priority patent/WO2000002592A1/en
Publication of JP2002520300A publication Critical patent/JP2002520300A/ja
Publication of JP2002520300A5 publication Critical patent/JP2002520300A5/ja
Withdrawn legal-status Critical Current

Links

JP2000558851A 1998-07-09 1999-06-18 Gaba類縁体及び抗ウイルス剤を含んでなる帯状ヘルペスを治療するための医薬組成物 Withdrawn JP2002520300A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9217198P 1998-07-09 1998-07-09
US60/092,171 1998-07-09
PCT/US1999/013947 WO2000002592A1 (en) 1998-07-09 1999-06-18 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles

Publications (2)

Publication Number Publication Date
JP2002520300A JP2002520300A (ja) 2002-07-09
JP2002520300A5 true JP2002520300A5 (cg-RX-API-DMAC7.html) 2006-08-17

Family

ID=22231986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000558851A Withdrawn JP2002520300A (ja) 1998-07-09 1999-06-18 Gaba類縁体及び抗ウイルス剤を含んでなる帯状ヘルペスを治療するための医薬組成物

Country Status (17)

Country Link
EP (1) EP1093366B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002520300A (cg-RX-API-DMAC7.html)
KR (1) KR20010071776A (cg-RX-API-DMAC7.html)
AT (1) ATE279188T1 (cg-RX-API-DMAC7.html)
AU (1) AU765246B2 (cg-RX-API-DMAC7.html)
CA (1) CA2332929C (cg-RX-API-DMAC7.html)
DE (1) DE69921137T2 (cg-RX-API-DMAC7.html)
DK (1) DK1093366T3 (cg-RX-API-DMAC7.html)
ES (1) ES2230863T3 (cg-RX-API-DMAC7.html)
ID (1) ID27395A (cg-RX-API-DMAC7.html)
NO (1) NO20010116D0 (cg-RX-API-DMAC7.html)
NZ (2) NZ508489A (cg-RX-API-DMAC7.html)
PL (1) PL345337A1 (cg-RX-API-DMAC7.html)
PT (1) PT1093366E (cg-RX-API-DMAC7.html)
SI (1) SI1093366T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000002592A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200007169B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4334900A (en) 1999-04-09 2000-11-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1274306C (zh) 2001-09-03 2006-09-13 纽朗制药有限公司 包含加巴喷丁或其类似物和α-氨基酰胺的药物组合物及其止痛应用
IN266803B (cg-RX-API-DMAC7.html) 2005-12-22 2015-06-03 Newron Pharm Spa
MX2007006093A (es) * 2007-05-21 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral.
KR20160095358A (ko) 2015-02-03 2016-08-11 고려대학교 산학협력단 우고닌 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 헤르페스 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111138A (en) * 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9321394D0 (en) * 1993-10-16 1993-12-08 Smihtkline Beecham P L C Pharmaceuticals
EA001214B1 (ru) * 1996-03-14 2000-12-25 Варнер-Ламберт Компани Новые мостиковые циклические аминокислоты как фармацевтически применимые вещества
EP0934061B3 (en) * 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain

Similar Documents

Publication Publication Date Title
JP2002520286A5 (cg-RX-API-DMAC7.html)
JP2002508352A5 (ja) 4(3)置換−4(3)−アミノメチル−(チオ)ピラン又はピペリジン誘導体(=ガバペンチン類似体)
CA2669481A1 (en) Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2002519434A5 (cg-RX-API-DMAC7.html)
JP2001526218A5 (cg-RX-API-DMAC7.html)
JP2001525359A5 (cg-RX-API-DMAC7.html)
JP2002502874A5 (cg-RX-API-DMAC7.html)
JP2002518502A5 (cg-RX-API-DMAC7.html)
NZ504618A (en) Controlled release therapeutic formulation for administering tolterodine maintaining a constant serum level
JP2002541198A5 (ja) 失禁治療用医薬組成物
JP2004530641A5 (cg-RX-API-DMAC7.html)
LU91112I2 (fr) Pregabalin, facultativement sous forme d'un sel pharmaceutiquement acceptable.
JP2002519425A5 (cg-RX-API-DMAC7.html)
EP0601164A4 (en) Methods for treating viral infections.
CA2645558A1 (en) Regulation of phospholipase d activity
EP1484059A3 (en) Antiviral composition comprising phenylacetic acid derivatives
JP2002509153A5 (cg-RX-API-DMAC7.html)
KR880003958A (ko) 신규 세펨화합물 및 그의 제조방법
JP2003503449A5 (cg-RX-API-DMAC7.html)
JP2002519355A5 (cg-RX-API-DMAC7.html)
HU9603592D0 (en) Aryl-sulfonamido-hydroxamic acids of matrix-metalloproteinase-inhibiting activity
CA2446622A1 (en) Isostearic acid salts as permeation enhancers
JP2002506864A5 (cg-RX-API-DMAC7.html)
JP2002503714A5 (cg-RX-API-DMAC7.html)